Categories: BioTechDeliveryEconomyEdTechInteriorMedTechPlatformResearchTechnologyUniversity
NanoSyrinx is a discovery stage biotechnology company developing new therapeutic modalities for Cell & Gene editing. This is the first company to engineer ‘nanosyringes’, a selective non-viral peptide and protein delivery system identified in an undisclosed organism. NanoSyrinx is developing a fully customisable genetic platform that selectively delivers peptide and protein payloads – including functional gene editing enzymes and nucleases – directly to the cytosol of targeted cells. NanoSyrinx is based at the University of Warwick’s Medical School.
Investors 3
Funding Rounds 2
Date | Series | Amount | Investors |
11.12.2021 | Seed | $8.23M | - |
19.07.2021 | - | $8.5M | - |
Mentions in press and media 7
Date | Title | Description | Source |
11.12.2021 | NanoSyrinx announces oversubscribed £6.2M Seed+ funding roun... | NanoSyrinx has raised a further £6.2m of seed financing, co-led by incoming Octopus Ventures and exi... | m-ventures... |
19.07.2021 | NanoSyrinx raises £6.2m to develop synthetic biology platfor... | NanoSyrinx raises £6.2m to develop synthetic biology platform for targeted intracellular engineering... | cambridgen... |
19.07.2021 | In Five9 deal, Zoom targets growth with customers that canno... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
19.07.2021 | NanoSyrinx raises £6.2m to develop synthetic biology platfor... | NanoSyrinx, a biotech company developing a new cell engineering tool for novel targeted therapeutic ... | cambridgen... |
19.07.2021 | In Five9 deal, Zoom targets growth with customers that canno... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
19.07.2021 | Coventry-based biotech grabs £6.2M funding to develop its no... | Coventry-based biotech, NanoSyrinx has raised a further £6.2m of seed financing, co-led by incoming ... | uktech.new... |
- | Coventry-based biotech grabs £6.2M funding to develop its no... | Coventry-based biotech, NanoSyrinx has raised a further £6.2m of seed financing, co-led by incoming ... | uktech.new... |
Reviews 0